Elanco Animal Health Incorporated (ELAN)

USD 11.73

(-4.71%)

Net Debt Summary of Elanco Animal Health Incorporated

Elanco Animal Health Incorporated's latest annual net debt in 2023 was 5.42 Billion USD , down -1.26% from previous year.
Elanco Animal Health Incorporated's latest quarterly net debt in 2024 Q2 was 5.26 Billion USD , down -2.95% from previous quarter.
Elanco Animal Health Incorporated reported annual net debt of 5.49 Billion USD in 2022, down -3.34% from previous year.
Elanco Animal Health Incorporated reported annual net debt of 5.68 Billion USD in 2021, up 0.87% from previous year.
Elanco Animal Health Incorporated reported quarterly net debt of 5.26 Billion USD for 2024 Q2, down -2.95% from previous quarter.
Elanco Animal Health Incorporated reported quarterly net debt of 5.42 Billion USD for 2023 FY, down -1.26% from previous quarter.

Annual Net Debt Chart of Elanco Animal Health Incorporated (2023 - 2016)

Historical Annual Net Debt of Elanco Animal Health Incorporated (2023 - 2016)

Year	Net Debt	Net Debt Growth
2023	5.42 Billion USD	-1.26%
2022	5.49 Billion USD	-3.34%
2021	5.68 Billion USD	0.87%
2020	5.63 Billion USD	178.68%
2019	2.02 Billion USD	1.18%
2018	1.99 Billion USD	717.66%
2017	-323.4 Million USD	-24.96%
2016	-258.8 Million USD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	5.42 Billion USD	-0.04%
2024 Q2	5.26 Billion USD	-2.95%
2023 FY	5.42 Billion USD	-1.26%
2023 Q1	5.7 Billion USD	3.84%
2023 Q2	5.69 Billion USD	-0.12%
2023 Q3	5.54 Billion USD	-2.72%
2023 Q4	5.42 Billion USD	-2.13%
2022 Q2	5.55 Billion USD	-4.07%
2022 FY	5.49 Billion USD	-3.34%
2022 Q4	5.49 Billion USD	0.92%
2022 Q3	5.44 Billion USD	-2.07%
2022 Q1	5.79 Billion USD	1.95%
2021 Q2	5.51 Billion USD	-2.28%
2021 Q3	5.88 Billion USD	6.6%
2021 FY	5.68 Billion USD	0.87%
2021 Q4	5.68 Billion USD	-3.4%
2021 Q1	5.64 Billion USD	0.25%
2020 Q1	855.2 Million USD	-57.68%
2020 Q2	665.2 Million USD	-22.22%
2020 Q3	5.48 Billion USD	723.84%
2020 FY	5.63 Billion USD	178.68%
2020 Q4	5.63 Billion USD	2.77%
2019 Q4	2.02 Billion USD	-1.46%
2019 Q1	2.19 Billion USD	9.81%
2019 Q3	2.05 Billion USD	1.33%
2019 FY	2.02 Billion USD	1.18%
2019 Q2	2.02 Billion USD	-7.73%
2018 Q1	323.4 Million USD	200.0%
2018 FY	1.99 Billion USD	717.66%
2018 Q4	1.99 Billion USD	-8.31%
2018 Q3	2.17 Billion USD	778.66%
2018 Q2	-321 Million USD	-199.26%
2017 Q1	258.8 Million USD	0.0%
2017 Q4	-323.4 Million USD	0.0%
2017 FY	-323.4 Million USD	-24.96%
2016 FY	-258.8 Million USD	0.0%

Peer Net Debt Comparison of Elanco Animal Health Incorporated

Name	Net Debt	Net Debt Difference
Amneal Pharmaceuticals, Inc.	2.65 Billion USD	-103.913%
Bausch Health Companies Inc.	21.44 Billion USD	74.712%
Catalent, Inc.	4.69 Billion USD	-15.386%
Emergent BioSolutions Inc.	765.8 Million USD	-608.018%
Perrigo Company plc	3.32 Billion USD	-63.21%
Teva Pharmaceutical Industries Limited	16.92 Billion USD	67.968%
Zoetis Inc.	4.76 Billion USD	-13.86%